Tag: Arrowhead Pharmaceuticals

Cell and Gene Therapy, Industry

Arrowhead Pharmaceuticals: Pushing the Boundaries of Gene Silencing

February 27, 2020

Via: BioSpace

RNA interference (RNAi), sometimes called gene silencing, is an approach to therapeutics in certain diseases that are caused by the production of abnormal proteins or an overproduction of proteins, which can be treated by turning off or silencing the gene. […]